Davies, Neil M <br/><br/>
The Food and Drug Administration and varenicline: should risk communication be improved?  [electronic resource] 

 -  Addiction (Abingdon, England)  04 2017 
 - 555-558 p.  digital 
<br/><br/> Publication Type: Editorial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1360-0443 
<br/><br/><label>Standard No.: </label>10.1111/add.13592  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drug Labeling--methods<br/>Health Communication--methods<br/>Humans<br/>Nicotinic Agonists--adverse effects<br/>Risk<br/>United States<br/>United States Food and Drug Administration<br/>Varenicline--adverse effects